Related Experiment Video
Updated: Apr 3, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Characterization of Staphylococcus aureus infections in children with Down syndrome
Jeffrey N Johnston1, Sheldon L Kaplan1, Edward O Mason1
1Texas Children's Hospital, Department of Pediatrics, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX, United States.
Insights
Staphylococcus aureus infections in children with Down syndrome (DS) are often skin or ear infections, with a high rate of MRSA. Recurrent ear infections showed resistance to antiseptics and fluoroquinolones.
Area of Science:
- Infectious Diseases
- Microbiology
- Genetics
Background:
- Staphylococcus aureus infections in individuals with Down syndrome (DS) are not well-understood.
- Characterizing these infections is crucial for appropriate clinical management and public health strategies.
Purpose of the Study:
- To determine the clinical and molecular characteristics of Staphylococcus aureus infections in children with Down syndrome.
- To identify specific resistance patterns and virulence factors in S. aureus isolates from this population.
Main Methods:
- Retrospective review of medical records for children with DS and S. aureus infections from 2001-2011.
- Molecular characterization of isolates including antimicrobial susceptibility, pulsed-field gel electrophoresis, and detection of resistance genes (pvl, mupA, smr) and SCCmec type.
Main Results:
- 34 S. aureus infections in 26 children with DS were identified; 61% were MRSA.
- Skin and soft tissue infections (SSTI) were most common (17/26), followed by ear infections (7/26).
- Recurrent ear infections (5/8) were associated with antiseptic (smr+) and fluoroquinolone resistance genes.
Conclusions:
- S. aureus infections in DS patients present similarly to other groups, but with a higher prevalence of ear infections.
- Ear isolates frequently carried antiseptic and fluoroquinolone resistance genes, highlighting a potential challenge in treatment.
- Further research with larger cohorts of DS patients is needed to validate these findings.
Abstract:
Staphylococcus aureus infections in the Down syndrome (DS) population have not been well characterized. This study determined clinical and molecular characteristics of S. aureus infections in children with DS followed at Texas Children's Hospital (TCH), from 2001 to 2011. Patients were retrospectively identified from an ongoing S. aureus surveillance study. Medical records were reviewed. Isolates were characterized by antimicrobial susceptibility, pulsed-field gel electrophoresis patterns, and detection of PVL genes (pvl), mupA (high-level mupirocin resistance gene), smr (chlorhexidine resistance conferring gene), and Staphylococcal Chromosomal Cassette mec (SCCmec) type. Twenty-six patients with DS had a total of 34 S. aureus infections (8 recurrent); 61% were MRSA. DS patients represented 16.8 per 10,000 community onset S. aureus infections seen at TCH. Among 26 initial infections 17 were skin and soft tissue (SSTI), 7 were outer or middle ear and 2 were invasive infections. Seventeen patients were hospitalized. Thirteen (65%) of 20 available isolates were USA300, 14 were pvl+, 5 were mupA+, and 8 were smr+. Five of 8 (63%) recurrent infections were ear infections. All 4 recurrent ear isolates available for study were smr+, ciprofloxacin non-susceptible and treated with ciprofloxacin otic drops. S. aureus infections among patients with DS were similar in presentation to other patient groups, except for a greater proportion being associated with ear infections. Seventy percent of ear fluid isolates carried antiseptic and fluoroquinolone resistance genes. A study of a greater number of DS patients is warranted to further explore these findings.
Related Concept Videos
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance
Karyotyping
Atypical Pneumonia
Mechanism of Antibiotic Resistance in MRSA
Immunodeficiency Diseases
There are three main causes of immunodeficiency...

